Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Amyloid Beta 1-40 Measurement

Known as: Amyloid Beta 40, Amyloid Beta 40 Protein, Amyloid Beta 1-40 
The determination of the amount of amyloid beta protein which is composed of peptides 1 to 40 in a sample.
National Institutes of Health

Related topics

Related topics

3 relations
CDISC SDTM Laboratory Test Terminology by CodeCDISC SDTM Laboratory Test Terminology by NameClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Insulin differentially affects the distribution kinetics of amyloid beta 40 and 42 in plasma and brain
Impaired brain clearance of amyloid-beta peptides (Aβ) 40 and 42 across the blood–brain barrier (BBB) is believed to be one of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder.
OBJECTIVE Major depressive disorder is common in the elderly, and symptoms are often not responsive to conventional… Expand
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Centella asiatica extract selectively decreases amyloid beta levels in hippocampus of Alzheimer's disease animal model.
PSAPP mice expressing the 'Swedish' amyloid precursor protein and the M146L presenilin 1 mutations are a well-characterized model… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Abeta42-Induced Neurodegeneration via an Age-Dependent Autophagic-Lysosomal Injury in Drosophila
The mechanism of widespread neuronal death occurring in Alzheimer's disease (AD) remains enigmatic even after extensive… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology.
Neuroinflammation is a conspicuous feature of Alzheimer disease (AD) pathology and is thought to contribute to the ultimate… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2006
2006
Diagnostic and therapeutic potential of amyloid-reactive IgG antibodies contained in human sera.
Passive immunotherapy using fibril-reactive mAbs has been shown experimentally to reduce amyloid formation and also accelerate… Expand
Is this relevant?
2006
2006
Decreased cerebrospinal fluid amyloid beta (1-40) levels in frontotemporal lobar degeneration.
The role of amyloid metabolism in the pathophysiology of frontotemporal lobar degeneration (FTLD) has yet to be elucidated. We… Expand
Is this relevant?
Highly Cited
2005
Highly Cited
2005
A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease
BackgroundAlzheimer's disease (AD) is a progressive neurodegenerative disorder that primarily strikes the elderly. Studies in… Expand
  • table 1
  • figure 2
  • table 2
Is this relevant?
2000
2000
Plasma levels of amyloid beta 40 and 42 are independent from ApoE genotype and mental retardation in Down syndrome.
In Down syndrome (DS) brain an early, selective accumulation of amyloid beta (Abeta) peptides ending at residue 42 (Abeta42… Expand
Is this relevant?
Review
1995
Review
1995
Amyloid beta amyloidosis in Alzheimer's disease.
The presence of amyloid deposits in the parenchyma of the amygdala, hippocampus, and neocortex is a major histopathological… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE